| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 |
|---|---|---|---|---|---|---|
Revenue: | ||||||
Total revenue | ||||||
216,824 | 147,699 | 68,221 | 25,048 | 8,378 | 1,604 | 148 |
Cost of test revenue | ||||||
118,103 | 80,105 | 50,142 | 27,878 | 16,523 | 5,624 | 667 |
Research and development | ||||||
141,526 | 63,496 | 46,469 | 44,630 | 42,806 | 22,063 | 16,039 |
Selling and marketing | ||||||
122,237 | 74,428 | 53,417 | 28,638 | 22,479 | 8,669 | 2,431 |
General and administrative | ||||||
79,070 | 52,227 | 39,472 | 24,085 | 16,047 | 12,600 | 5,764 |
Total costs and operating expenses | ||||||
- | - | - | 125,231 | 97,855 | 48,956 | 24,901 |
Operating Income (Loss) | ||||||
-244,112 | -122,557 | -121,279 | -100,183 | -89,477 | -47,352 | -24,753 |
Other income, net | ||||||
-3,891 | -2,568 | -303 | 348 | -94 | -79 | -26 |
Interest expense | ||||||
12,412 | 7,030 | 3,654 | 421 | 211 | 61 | 59 |
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | ||||||
-260,415 | -132,155 | -125,236 | -100,256 | -89,782 | - | - |
Income Tax Expense (Benefit) | ||||||
-18,450 | -2,800 | -1,856 | 0 | 0 | - | - |
Net Income (Loss) Attributable to Parent | ||||||
-241,965 | -129,355 | -123,380 | -100,256 | -89,782 | -47,492 | -24,838 |
Net loss attributable to common stockholders | ||||||
- | - | - | - | - | - | -24,989 |
Net loss per share, basic and diluted (in dollars per share) | ||||||
-2.66 | -1.94 | -2.65 | -3.02 | -3.18 | -56.14 | -36.13 |
Shares used in computing net loss per share, basic and diluted | ||||||
90,859 | 66,747 | 46,512 | 33,176 | 28,213 | 846 | 691 |
Test revenue | ||||||
Total revenue | ||||||
212,473 | 144,560 | 65,169 | 24,840 | 8,378 | - | - |
Other revenue | ||||||
Total revenue | ||||||
4,351 | 3,139 | 3,052 | 208 | - | - | - |